Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports

被引:0
作者
Ali AL Zahrani
Ali Alfakeeh
机构
[1] King Fahad Medical City,Department of Medical Oncology, Comprehensive Cancer Center
来源
Journal of Medical Case Reports | / 15卷
关键词
Fibrolamellar hepatocellular carcinoma; Atezolizumab; Bevacizumab; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 152 条
[1]  
Edmondson HA(1956)Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood Am J Dis Child 91 168-1455
[2]  
Berman MM(1980)Hepatocellular carcinoma: polygonal cell type with fibrous stroma—an atypical variant with a favorable prognosis Cancer 46 1448-379
[3]  
Libbey NP(1980)Fibrolamellar carcinoma of the liver, a tumor of adolescents and young adults with distinctive clinic-pathologic features Cancer 46 372-32
[4]  
Foster JH(2013)Histopathology of hepatocellular carcinoma. Recent results Cancer Res 190 21-137
[5]  
Craig JR(2002)Fibrolamellar hepatocellular carcinoma in Mexican patients Pathol Oncol Res 8 133-1668
[6]  
Peters RL(2013)Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10 Gut 62 1667-357
[7]  
Edmondson HA(2013)Fibrolamellar hepatocellular carcinoma in the USA, 2000–2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database United Eur Gastroenterol J 1 351-2624
[8]  
Omata M(2009)Fibrolamellar hepatocellular carcinoma Am J Gastroenterol 104 2617-1014
[9]  
Paradis V(2014)Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma Science 343 1010-59
[10]  
Arista-Nasr J(2018)Fibrolamellar carcinoma: recent advances and unresolved questions on the molecular mechanisms Semin Liver Dis 38 51-656